Literature DB >> 2035837

Procedure for the purification of the fibronectin proteolytic fragments containing the ED-B oncofetal domain.

L Borsi1, E Balza, A Leprini, M Ponassi, L Zardi.   

Abstract

Fibronectin (FN) is the blend of structurally different molecules (isoforms) whose makeup varies depending on the FN sources. Fibronectin polymorphism is caused by three sequences (called ED-A, ED-B, and IIICS) which may be included or excluded from the FN molecule depending on the alternative splicing patterns of a single primary transcript. The sequence ED-B, which is a complete type III repeat of 91 amino acids, presents some interesting peculiarities: it is the most conserved FN region and, in normal adult tissues, the ED-B-containing FN has an extremely restricted distribution while having a much greater expression in fetal and tumor tissues (Carnemolla et al., 1989, J. Cell Biol. 108, 1139-1148), suggesting that the ED-B sequence may confer to the FN molecules specific biological activities required during ontogenesis and oncogenetic processes. Here we describe a detailed procedure to purify fibronectin fragments containing the ED-B sequence. These purified fragments are useful reagents in the study of the biological function(s) of the ED-B-containing FN molecules.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2035837     DOI: 10.1016/0003-2697(91)90551-4

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  5 in total

1.  Immunohistochemistry of the intercellular matrix components and the epithelio-mesenchymal junction of the human tooth germ.

Authors:  C Garbarsch; M E Matthiessen; B E Olsen; D Moe; S Kirkeby
Journal:  Histochem J       Date:  1994-02

2.  Anti-adhesive glycosylation of fibronectin-like molecules in human placental matrix-type fibrinoid.

Authors:  H G Frank; B Huppertz; S Kertschanska; D Blanchard; D Roelcke; P Kaufmann
Journal:  Histochem Cell Biol       Date:  1995-10       Impact factor: 4.304

3.  L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model.

Authors:  Paola Orecchia; Enrica Balza; Gabriella Pietra; Romana Conte; Nicolò Bizzarri; Simone Ferrero; Maria Cristina Mingari; Barbara Carnemolla
Journal:  Cancers (Basel)       Date:  2019-08-23       Impact factor: 6.639

4.  The alternatively spliced type III connecting segment of fibronectin is a zinc-binding module.

Authors:  Janet A Askari; David J Thornton; Jonathan D Humphries; Patrick A Buckley; Martin J Humphries
Journal:  Matrix Biol       Date:  2007-04-06       Impact factor: 11.583

5.  Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions.

Authors:  P G Natali; M R Nicotra; F Di Filippo; A Bigotti
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.